Sky Century Investment, Inc. (SKYI) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SKYI representa a Sky Century Investment, Inc., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 57/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 17 mar 2026Sky Century Investment, Inc. (SKYI) Resumen de Asistencia Médica y Tuberías
Sky Century Investment, Inc. is a micro-cap company involved in the sale of CBD products and digital marketing services for the CBD industry, operating with a small team and facing significant competition in the specialty and generic drug manufacturing sector, as well as the digital marketing space.
Tesis de Inversión
Sky Century Investment, Inc. presents a high-risk, high-reward investment profile due to its micro-cap status and involvement in the volatile CBD market. With a market capitalization of $0.00B and a negative P/E ratio of -4.52, the company's financial performance raises concerns. A key value driver would be successful expansion of its CBD product line and digital marketing services, potentially increasing revenue and improving profitability. Growth catalysts include capitalizing on the increasing acceptance and legalization of CBD products. However, potential risks include intense competition, regulatory uncertainty surrounding the CBD industry, and the company's limited resources. Investors should carefully consider these factors before investing.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market Cap of $0.00B indicates the company's micro-cap status, reflecting its small size and limited market presence.
- P/E Ratio of -4.52 suggests the company is currently not profitable, indicating potential challenges in generating earnings.
- Profit Margin of -116.0% highlights significant losses relative to revenue, raising concerns about the company's financial sustainability.
- Gross Margin of 33.5% indicates the profitability of the company's products and services before operating expenses are considered.
- Beta of 0.88 suggests the stock is slightly less volatile than the overall market.
Competidores y Pares
Fortalezas
- Focus on pharmaceutical-grade ingredients.
- Digital marketing services tailored to the CBD industry.
- Established presence in the CBD market since 2012.
Debilidades
- Small size and limited resources (1 employee).
- Negative profitability and low market capitalization.
- High dependence on the volatile CBD market.
Catalizadores
- Ongoing: Increasing acceptance and legalization of CBD products could drive demand.
- Upcoming: Potential partnerships with established healthcare companies.
- Upcoming: Expansion into new geographic markets.
Riesgos
- Ongoing: Intense competition in the CBD and digital marketing industries.
- Ongoing: Regulatory uncertainty surrounding the CBD market.
- Potential: Fluctuations in consumer demand for CBD products.
- Potential: Limited financial resources and negative profitability.
- Potential: Dependence on a single employee.
Oportunidades de crecimiento
- Expansion of CBD Product Line: Sky Century Investment can explore developing new CBD-infused products, such as topicals, edibles, and beverages, to cater to a broader consumer base. The global CBD market is projected to reach billions of dollars in the coming years, offering significant revenue potential. Timeline: Within the next 1-2 years, the company could launch new product lines, pending regulatory approvals and market research.
- Strategic Partnerships: Collaborating with established healthcare or wellness companies could provide Sky Century Investment with access to wider distribution networks and increased brand recognition. Partnerships could also facilitate research and development efforts, leading to innovative CBD products. Timeline: Initiating partnership discussions within the next 6-12 months could lead to mutually beneficial agreements.
- Geographic Expansion: Targeting new geographic markets, both domestically and internationally, can significantly increase Sky Century Investment's customer base. Identifying regions with favorable CBD regulations and high consumer demand is crucial. Timeline: Market research and regulatory analysis within the next year could pave the way for expansion into new territories.
- Digital Marketing Service Enhancement: Sky Century Investment can enhance its digital marketing services by incorporating emerging technologies such as AI-powered marketing automation and personalized advertising. This can attract more clients in the CBD industry and increase revenue from its service offerings. Timeline: Implementing new digital marketing technologies within the next 6-12 months can improve service efficiency and attract new clients.
- Focus on Pharmaceutical-Grade CBD: Emphasizing the use of pharmaceutical-grade ingredients in its CBD products can differentiate Sky Century Investment from competitors and appeal to health-conscious consumers. This can also open doors to potential collaborations with pharmaceutical companies for research and development. Timeline: Strengthening supply chain relationships and obtaining relevant certifications within the next year can enhance product quality and market credibility.
Oportunidades
- Expansion into new CBD product lines.
- Strategic partnerships with established healthcare companies.
- Geographic expansion into new markets.
Amenazas
- Intense competition in the CBD and digital marketing industries.
- Regulatory uncertainty surrounding the CBD market.
- Fluctuations in consumer demand for CBD products.
Ventajas competitivas
- Focus on pharmaceutical-grade ingredients may provide a quality advantage.
- Digital marketing services tailored to the CBD industry offer a niche specialization.
- Early mover advantage in a rapidly growing market (though competition is increasing).
Acerca de SKYI
Sky Century Investment, Inc., incorporated in 2012 and based in Las Vegas, Nevada, operates within the healthcare sector, specifically in the specialty and generic drug manufacturing industry, with a focus on cannabidiol (CBD) products. The company's business model encompasses two primary areas: the sale of CBD products formulated with pharmaceutical-grade ingredients, and the provision of digital marketing services. These services include digital marketing strategy and planning, search engine optimization (SEO), analytics, and reporting. Additionally, Sky Century Investment offers content and website development and mail marketing services tailored for companies involved in the production of CBD products. Given its small size, with only one employee, Sky Century Investment's market reach and operational capacity are limited. The company's focus on the CBD market positions it within a rapidly growing but also highly competitive segment of the healthcare industry. Its dual approach of offering both CBD products and marketing services aims to capitalize on the increasing demand for CBD and the need for effective marketing strategies within this sector.
Qué hacen
- Sells cannabidiol (CBD) products.
- Uses pharmaceutical-grade ingredients in CBD products.
- Provides digital marketing services.
- Offers strategy and planning services.
- Provides SEO, analytics, and reporting services.
- Offers content and website development services.
- Provides mail marketing services for CBD companies.
Modelo de Negocio
- Direct sales of CBD products to consumers.
- Providing digital marketing services to companies in the CBD industry.
- Generating revenue through service fees and product sales.
Contexto de la Industria
Sky Century Investment, Inc. operates in the rapidly evolving CBD market within the broader healthcare sector. The CBD industry is characterized by increasing consumer demand, driven by perceived health benefits and growing acceptance of cannabis-derived products. However, the market is also highly competitive, with numerous companies vying for market share. Regulatory uncertainty at both the state and federal levels adds another layer of complexity. Sky Century Investment's dual focus on CBD products and digital marketing services positions it to capitalize on the growth of the CBD market, but it faces competition from larger, more established players in both the CBD and digital marketing spaces.
Clientes Clave
- Individual consumers seeking CBD products.
- Companies in the CBD industry needing digital marketing services.
- Businesses involved in the production of CBD products.
Finanzas
Gráfico e información
Precio de la acción de Sky Century Investment, Inc. (SKYI): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para SKYI.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para SKYI.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para SKYI.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de SKYI en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Nataliia Petranetska
Managing Director
Nataliia Petranetska serves as the Managing Director of Sky Century Investment, Inc. Her background includes experience in managing small teams and overseeing the company's operations in the CBD and digital marketing sectors. She is responsible for the strategic direction and day-to-day management of the company.
Historial: As the Managing Director, Nataliia Petranetska has focused on establishing Sky Century Investment's presence in the CBD market and developing its digital marketing service offerings. Key milestones under her leadership include expanding the company's product line and securing contracts with CBD companies for marketing services.
Información del mercado OTC de SKYI
The OTC Other tier represents the lowest tier of the OTC market, indicating that Sky Century Investment, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies often have less stringent listing requirements and may be subject to less regulatory oversight.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure due to OTC Other status.
- Low liquidity and potential price volatility.
- Higher risk of fraud or manipulation compared to listed exchanges.
- Limited regulatory oversight.
- Dependence on the volatile CBD market.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's competitive position in the CBD market.
- Evaluate the company's compliance with relevant regulations.
- Understand the company's business model and revenue streams.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Company has been in operation since 2012.
- Focus on pharmaceutical-grade ingredients.
- Provides digital marketing services to other CBD companies.
Preguntas Comunes Sobre SKYI
¿Cuáles son los factores clave para evaluar SKYI?
Sky Century Investment, Inc. (SKYI) actualmente tiene una puntuación IA de 57/100, indicando puntuación moderada. Fortaleza clave: Focus on pharmaceutical-grade ingredients.. Riesgo principal a monitorear: Ongoing: Intense competition in the CBD and digital marketing industries.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de SKYI?
SKYI actualmente puntúa 57/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de SKYI?
Los precios de SKYI se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre SKYI?
La cobertura de analistas para SKYI incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en SKYI?
Las categorías de riesgo para SKYI incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition in the CBD and digital marketing industries.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de SKYI?
La relación P/E para SKYI compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está SKYI sobrevalorada o infravalorada?
Determinar si Sky Century Investment, Inc. (SKYI) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de SKYI?
Sky Century Investment, Inc. (SKYI) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available for this company.
- OTC stocks are inherently riskier than exchange-listed stocks.
- AI analysis pending.